Finimize - 🦾 OpenAI's big target

OpenAI is aiming for one billion users, China's manufacturing activity was up, and one intrepid cat |
Finimize

Hi Reader, here's what you need to know for December 3rd in 3:14 minutes.

  1. OpenAI said it’s got a plan to quadruple its ChatGPT user base in the coming year
  2. How to find a winning stock among the firms that eat their own – Read Now
  3. China's manufacturing grew in November, driven by a bounceback in export demand

💥 Starting today: the one and only Mellody Hobson kicks off our Modern Investor Summit at 2pm UK time, before world-class finance pros discuss the hottest themes from AI to alternative investments to building a stronger portfolio. Secure your spot for free

The Magic Number
The Magic Number

What’s going on here?

ChatGPT parent OpenAI is setting its sights on attaining one billion users in the coming year, and it’s got some big plans to get it there.

What does this mean?

Two years ago, OpenAI introduced ChatGPT to the world. And, at the time, startup insiders predicted that the AI chatbot would attract a few hundred thousand users. Turns out they were way off: ChatGPT went to the moon, becoming the fastest-growing app in history and now boasting around 250 million weekly active users. Fast-forward to this week, and OpenAI has laid out an ambitious goal: reaching one billion users in the next year. To get there, it’s releasing some new AI products, including its own search engine and “agents” – chatbot-like assistants that can help get stuff done on the web. It’s also recently partnered with Apple, which will integrate ChatGPT across its billions of devices. And with all that happening, perhaps its goal of quadrupling its customer base isn’t so farfetched after all.

Why should I care?

For markets: Winners and… winners.

OpenAI has seen its valuation skyrocket to $157 billion – the highest ever for a Silicon Valley startup and five times the $29 billion it fetched back in April 2023. Mind you, the biggest winners from the AI boom that its chatbot almost singlehandedly launched are a handful of US tech firms. In fact, the six heftiest – Nvidia, Microsoft, Apple, Amazon, Meta, and Alphabet – have seen their combined market value grow by more than $8 trillion since ChatGPT’s debut.

The bigger picture: No growing pains here.

It’s not hard to understand investors’ enthusiasm for all things AI, especially considering the massive growth that’s expected for it. Consider this: the market for AI-related services and hardware hit $185 billion last year. That’s not small potatoes, but consultancy firm Bain expects it to expand by 40% to 55% every year until 2027, potentially reaching $1 trillion.

Copy to share story: https://app.finimize.com/content/the-magic-number

🙋 Ask a question

TODAY'S INSIGHT

Corporate Cannibals Are Out There: Here’s How To Profit From Them

Theodora Lee Joseph, CFA

Corporate Cannibals Are Out There: Here’s How To Profit From Them

Corporate cannibals – a term affectionately coined for companies that devour their own shares through aggressive buybacks – offer a fascinating opportunity for investors.

But, as you could probably guess, not all share buybacks are created equal.

Some are a savvy move aimed at rewarding shareholders, while others are a bright red flag.

Here’s how to know the difference and how to profit from the firms that eat their own.

That’s today’s Insight: how to find opportunities among the firms that eat their own.

Read or listen to the Insight here

Breaking Business News

Intel CEO Pat Gelsinger has retired from the struggling US chipmaker, after trying and failing to turn around the once-iconic tech firm.

So today's must-read Research is: Intel may be too important to fail – and too cheap to pass up.

* SPONSORED BY MEIRA GTX

Breaking barriers is in its genes

Big breakthroughs can often bring big investing opportunities – and MeiraGTx might just be delivering both.

The Nasdaq-listed biotech firm is pushing the limits of genetic medicine, helping it develop critical new treatments for Parkinson’s, ALS, Xerostomia, and multiple inherited ocular diseases.

Its work has earned MeiraGTx the backing of pharma heavyweights Johnson & Johnson and Sanofi – and a $534 million market value.

Even better: the firm has become well-positioned to lead in a booming, multi-billion-dollar market.

So visit MeiraGTx’s Curation Connect page to find out more about its late-stage clinical trials and groundbreaking work.

Discover More

This content is a paid advertisement for MeiraGTx from Curation Connect and Finimize. This is not Finimize editorial content. Finimize received a fixed fee from Curation Connect for producing, hosting and promoting this content via three email sends on behalf of MeiraGTx, totalling £8,000. Other than the compensation received for this service, Finimize and its principals are not affiliated with either Curation Connect or MeiraGTx. Finimize and its principals have no ownership in MeiraGTx.

The content on this page should not be taken as advice, an endorsement, or a recommendation from Finimize and its principals to buy or sell any security. Finimize and its principals have not evaluated the accuracy of any claims made on this page. Finimize and its principals recommend that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky and capital is at risk. Past performance is not indicative of future results.

When you support our sponsors, you support us. Thanks for that.

If you want your brand featured here, get in touch.

Recovery In The Making
Recovery In The Making

What’s going on here?

China’s gigantic manufacturing sector saw a nice boost of activity in November, helped by a surge of new orders and some government stimulus.

What does this mean?

The Caixin manufacturing purchasing managers index rose to a surprisingly strong 51.5, compared to 50.3 the month before. It was the factory sector’s second straight showing above the critical 50 mark that separates an expansion in activity from a contraction. The monthly survey of smaller firms in China showed orders were pouring in at their fastest pace in over three years, as exports bounced back. Meanwhile, the official manufacturing activity index – the one driven by bigger state-owned firms – also marched higher, suggesting this long-awaited improvement may actually have legs.

Why should I care?

For markets: Help before hindrance.

But there’s a catch here. The threat of new US tariffs may have caused some American companies to panic buy – pulling future demand forward. After all, the president-elect’s proposed 60% tax hike on goods shipped in from China could hit companies pretty hard: think-tank CF40 estimates that it would squeeze Chinese exports by 6.5%. So while these latest factory numbers might offer hope for the country’s recovery, they come with a side order of caution, because trade tensions and a weak property market are still clouding the outlook.

For you personally: Hard times for the high-end.

It’s not just manufacturing that’s been taking it on the chin: luxury goods have hit a rough patch too. Chinese consumers have been keeping their hands in their pockets, and that’s caused stock price stumbles for posh giants LVMH, L’Oréal, Estée Lauder, and Shiseido. And there could be a dazzling investing opportunity there. China is the world’s second-biggest luxury market, and recent government policies such as tax cuts, subsidies, and incentives could get its affluent shoppers spending again. So the latest dip in those shares could mark an attractive point for grabbing some luxury for less.

Copy to share story: https://app.finimize.com/content/recovery-in-the-making

🙋 Ask a question

QUOTE OF THE DAY

"Always remember that you are absolutely unique. Just like everyone else."

– Margaret Mead
Tweet this

Crack the code of options trading

Options trading doesn’t have to be a mystery.

Four key metrics – delta, gamma, theta, and vega – hold the answers to how options behave and what affects their value.

So we’ve teamed up with IG to create a no-nonsense guide that breaks them down.

Learn how delta tracks price changes, theta shows the impact of time, and gamma and vega help you manage risk – all in a bitesize, digestible format.

Whether you’re new to options or refining your strategy, this guide can give you the tools to make smarter, more informed trading decisions.

Read The Guide

Options and futures are complex instruments which come with a high risk of losing money rapidly due to leverage. You could lose more than your original investment.

🎯 On Our Radar

1. Keep it down. Discover the world’s last naturally quiet places.

2. Make moves with confidence. How to buy and sell options without the guesswork.*

3. Read all about it. Eleven great books for adventure athletes.

4. Build a portfolio that stands the test of time. Learn the key steps to long-term success with expert insights.*

5. One big journey. This cat wandered 900 miles from home.

When you support our sponsors, you support us. Thanks for that.

🌍 Finimize Live

🤩 Grab your tickets...

All events in UK time.
🚀 2024 Modern Investor Summit: Tuesday and Wednesday
Spotlighted Sessions:
📅
How To Adapt Your Portfolio For The Year Ahead: 2:45pm Tuesday
🤖 Investing In AI: Opportunities In Pre-IPO And Private Markets: 5:45pm Tuesday
🎅🏻 Beyond The Santa Claus Rally: How To Navigate High-Risk Trading In 2025: 8:15pm Tuesday

Thanks for reading Reader. If you liked today’s brief, we’d love for you to share it with a friend – here’s a link: Share this email

You stay classy, Reader 😉

Any thoughts on today’s email? Give feedback

Want to advertise with us? Get in touch

Image credits: Midjourney | Midjourney

Preferences:

Update your email or change preferences

View in browser

Unsubscribe from all Finimize Emails

Crafted by Finimize Ltd. | 280 Bishopsgate, London, EC2M 4AG

All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at finimize.com or through one of our partners. © Finimize 2024

View Online

When you support our sponsors, you support us. Thanks for that.

Older messages

🇪🇺 European inflation was warm

Friday, November 29, 2024

Eurozone inflation rose, India's growth slumped, and the world's most beautiful countries | Finimize TOGETHER WITH Hi Reader, here's what you need to know for November 30th in 3:02 minutes.

🦃 Chipmakers give thanks

Thursday, November 28, 2024

Potentially lighter tariffs was good news for chipmakers, France is down in the dumps, and an eternal flame | Finimize TOGETHER WITH Hi Reader, here's what you need to know for November 29th in 2:

🇺🇸 US inflation rose

Wednesday, November 27, 2024

US inflation sped up, German consumer confidence fell, and Champagne and turkey | Finimize Hi Reader, here's what you need to know for November 28th in 3:14 minutes. The US central bank's

💉 A slimming proposal

Tuesday, November 26, 2024

Obesity drugs could be covered for millions more Americans, the president-elect proposes new tariffs, and meat-eaters versus veggies | Finimize TOGETHER WITH Hi Reader, here's what you need to know

🤖 Amazon's buddy

Monday, November 25, 2024

Amazon invested big in Anthropic, a hedge fund manager was tapped for the US Treasury, and quacking at the bottom of the ocean | Finimize TOGETHER WITH Hi Reader, here's what you need to know for

You Might Also Like

Is your Medicare coverage falling short?

Tuesday, December 3, 2024

This may be the perfect time to get a Medigap plan Explore all your Medigap options All Medigap plans cover certain costs, such as copayments, coinsurance, and deductibles that Medicare doesn't

The Grass Isn’t Always Greener

Tuesday, December 3, 2024

Transplants are learning tough lessons ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Missed Out? Here’s Your Final Opportunity to Join F.A.S.T Profits!

Tuesday, December 3, 2024

Last call ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Dirt-cheap toys imported into U.S. can be dangerous

Tuesday, December 3, 2024

If you're tempted to buy kids' toys at rock-bottom prices online this holiday season, consumer advocates want you to think twice — and maybe three times. View this email online Planet Money I

Adaptation is to mitigation what Robin is to Batman

Tuesday, December 3, 2024

Jenny Clark and Theresa Löber The UK's climate continues to change, getting wetter and warmer, with extremes becoming ever more pronounced. Even if we limit global warming to 1.5°C above pre-

Identity theft is more common than you might think

Monday, December 2, 2024

Three in 10 Americans were affected in 2023 ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

The One-Big-Side-Bet Model of Wealth Creation

Monday, December 2, 2024

Plus! Diff Jobs; Building Japan's Financial Ecosystem; The New Balance of Trade; Where Return on Investment Goes; Broken ETFs; Swipe Fees and Accounting The One-Big-Side-Bet Model of Wealth

This is not a Cyber Monday deal

Monday, December 2, 2024

But you have one month free of Ellevest. ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌  ͏ ‌

Spring semester is approaching — are you ready?

Sunday, December 1, 2024

Invest in your career with a private student loan for grad school Your future starts today — apply for a private student loan Postgraduate studies can propel your career forward, helping unlock higher